|

Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction

RECRUITINGN/ASponsored by Thomas Engstrom
Actively Recruiting
PhaseN/A
SponsorThomas Engstrom
Started2015-05
Est. completion2024-03-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02445885

Summary

Although recommended therapy for patients with ST-segment elevation myocardial infarction is primary PCI, it remains unestablished whether patients with a symptom duration of more 12 hours benefit from acute revascularisation. This study aims to investigate whether acute intervention is superior to subacute intervention in these patients.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Inclusion criteria:
* Patients more than 18 years of age.
* STEMI \> 12 hours and \< 36 hours.
* Clinical stable, i.e. no on going angina, hemodynamically stable (systolic BP \> 90) and Killip class \< 3.

Exclusion Criteria:

* Clinical instability which requires an acute invasive strategy.
* Left main occlusion or multivessel disease which requires CABG.
* Previous Q-wave infarction in the current infarct related artery.
* Left Bundle Branch Block (LBBB).
* Severe renal insufficiency.
* Pacemaker
* Chronic atrial fibrillation.
* Previous Coronary Artery Bypass Surgery (CABG).
* Pregnancy.
* Other severe illness with life expectancy less than 1 year

Conditions3

Heart DiseaseIschemic Heart DiseaseST Segment Elevation Myocardial Infarction

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.